US Executive Compensation Proxy SEC Filings — June 09, 2026

09-06-2026

Haemonetics Corporation filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Shareholders scheduled for July 24, 2026. The meeting will include the election of eight director nominees, an advisory vote on executive compensation, ratification of Ernst & Young LLP as auditor, and approval of amendments to the 2019 Long-Term Incentive Compensation Plan and the 2007 Employee Stock Purchase Plan. The filing provides detailed executive compensation data for fiscal years 2022-2026, including pay versus performance disclosures, but does not contain financial results or operational metrics.

• · The annual meeting will be held on Friday, July 24, 2026 at 8:00 A.M. Eastern Time at 125 Summer Street, Boston, Massachusetts.
• · The record date for the meeting is May 22, 2026.
• · Proxy materials will be made available on or about June 10, 2026.
• · Shareholders will vote on six items: election of directors, advisory vote on executive compensation, ratification of auditor, approval of amended 2019 LTIP, approval of amended 2007 ESPP, and any other business.
• · The filing includes a CEO pay ratio disclosure and pay versus performance analysis for fiscal years 2022-2026.

09-06-2026

Singularity Future Technology Ltd. filed a definitive proxy statement (DEF 14A) for its annual meeting to re-elect directors Xu Zhao and Jinhao Pang, ratify Audit Alliance LLP as auditor, approve a 2026 Incentive Plan, authorize a reverse stock split (1:5, 1:10, or 1:14), and increase authorized shares from 50 million to 50 billion. The company had 7,293,492 shares outstanding as of the record date, reflecting a small equity base. The proposals signal potential dilution and a need to maintain Nasdaq listing compliance, though no financial performance data is provided in this filing.

• · The annual meeting will be held at 11:00 a.m. Eastern Time on a date to be announced.
• · A quorum requires at least one-third (1/3) of outstanding shares.
• · The reverse stock split must be effected no later than the first anniversary of stockholder approval.
• · Broker non-votes will have no effect on Proposals One, Three, Four, and Five, but Proposal Two (auditor ratification) is considered routine and brokers may vote without instructions.

09-06-2026

Cloudflare, Inc. filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders to be held on June 30, 2026. The filing includes proposals to elect three Class I directors, ratify the appointment of the independent registered public accounting firm, conduct an advisory vote on executive compensation, adopt an amended and restated certificate of incorporation, amend and restate the 2019 Plan and ESPP, and approve adjournments. The record date is June 5, 2026.

• · The Annual Meeting will be held virtually on June 30, 2026 at 8:30 AM Pacific Time.
• · Stockholders of record as of June 5, 2026 are entitled to vote.
• · Proposals include election of directors, ratification of auditor, advisory vote on compensation, charter amendment, 2019 Plan and ESPP amendments, and adjournment approval.

09-06-2026

Loop Industries, Inc. filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Stockholders to be held virtually on July 23, 2026. The meeting will include the election of five directors, ratification of PricewaterhouseCoopers LLP as auditor for fiscal 2027, an advisory vote on executive compensation, and an amendment to the 2017 Equity Incentive Plan to increase the share reserve. The filing also discloses that the sole holder of Series A Preferred Stock is entitled to 69,833,744 votes and the sole holder of Series B Convertible Preferred Stock is entitled to 2,544,537 votes as of the record date, significantly concentrating voting power.

• · The 2026 Annual Meeting will be held virtually on July 23, 2026 at 10:00 a.m. ET.
• · Record date for voting is May 26, 2026.
• · Proposal One requires a plurality vote; Proposals Two, Three, and Four require a majority of voting power present.
• · Broker non-votes will have no effect on the outcome of any proposal under Nevada law.
• · Stockholder proposals for the 2027 Annual Meeting must be received by February 8, 2027 to be included in the proxy statement.
• · The company is a controlled company due to the concentrated voting power of the Series A and Series B Preferred Stock holders.

09-06-2026

FS Credit Opportunities Corp. (FSCO) filed its definitive proxy statement (DEF 14A) for the 2026 annual meeting, detailing director elections, executive compensation (none paid by the company), and auditor ratification. The company is externally managed with no employees; executive officers are compensated by the adviser. Audit fees increased 3.6% to $378,871 in FY2025 from $365,650 in FY2024, while audit-related fees declined 50% to $20,000.

• · All Section 16(a) filing requirements for FY2025 were timely satisfied.
• · Ernst & Young has been the independent auditor since FY2013 through FY2025.
• · No fees were billed for 'all other fees' in FY2025 or FY2024.
• · The Audit Committee pre-approved all audit and permitted non-audit services for both fiscal years.
• · Director compensation for FY2025 ranged from $110,000 (Bethel, Clark) to $135,000 (Buckley).

09-06-2026

FS Specialty Lending Fund filed its definitive proxy statement (DEF 14A) for the 2026 annual meeting, recommending the election of trustee nominees Charles P. Pizzi and Pedro A. Ramos. The fund is externally managed with no employees; executive officers receive no direct compensation from the fund. Audit fees decreased slightly from $539,000 in FY2024 to $533,489 in FY2025, while audit-related fees rose from $0 to $71,000. All Section 16(a) filing requirements were timely satisfied during fiscal 2025.

• · The fund is externally managed under an Investment Advisory Agreement effective October 28, 2025 and an Administration Agreement dated October 28, 2025.
• · Trustees who are also executive officers receive no compensation from the fund; only independent trustees receive retainers and meeting fees.
• · All Section 16(a) filing requirements were timely satisfied during fiscal year ended December 31, 2025.
• · Ernst & Young has served as independent auditor since fiscal year 2013 through 2025.
• · Tax fees and all other fees billed by Ernst & Young were $0 for both FY2025 and FY2024.
• · Shareholder proposals for the 2027 annual meeting must be received by May 5, 2027.
• · The board unanimously recommends voting FOR each trustee nominee.

09-06-2026

NexGel, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders to be held on July 10, 2026. The meeting includes seven proposals: election of seven directors, approval of Nasdaq 20% issuance for shares from April/May 2026 private placements, reincorporation from Delaware to Nevada, a fallback increase in authorized shares from 25M to 100M, a fallback discretionary reverse stock split (1:2 to 1:10), an advisory vote on executive compensation, and ratification of auditors. The Board recommends a 'FOR' vote on all proposals.

• · Record date for voting is June 3, 2026.
• · Proposal 2 covers shares from April 2026 and May 2026 private placements, including anti-dilution adjustments and conversion price reset features.
• · Proposal 3 (reincorporation to Nevada) includes bundled provisions for 100M authorized shares and discretionary reverse stock split; if approved, Proposals 4 and 5 become moot.
• · Proposal 5 reverse stock split ratio range is 1-for-2 to 1-for-10, at Board discretion within one year of approval.
• · Proposal 7 seeks ratification of Turner, Stone & Company, L.L.P. as auditor for fiscal year ending December 31, 2026.
• · Proxy materials are available at www.proxyvote.com and were mailed on or about June 9, 2026.

09-06-2026

Power Solutions International, Inc. (PSIX) filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on July 23, 2026. The Board recommends voting FOR the election of seven director nominees, FOR ratification of BDO USA, P.C. as independent auditor for FY2026, FOR advisory approval of named executive officer compensation, and for a 1-year frequency on future say-on-pay votes. The filing details executive compensation, including the Summary Compensation Table, Long-Term Incentive Plan, and 2025 Key Performance Indicator Plan, but does not provide specific financial performance metrics or period-over-period comparisons.

• · Annual Meeting will be held virtually on July 23, 2026 at 8:00 a.m. Central Time.
• · Record date for voting is May 26, 2026.
• · Proposal 2 (ratification of auditor) is the only routine matter; broker discretionary voting is permitted only on that proposal.
• · The filing includes a Clawback Policy, Insider Trading Policy, and Hedging and Pledging Policy.
• · Director independence and controlled company exemption are discussed.

09-06-2026

XMax Inc. filed a DEF 14A proxy statement for a special meeting to seek shareholder approval for two proposals allowing the issuance of up to 100 million shares each via private placement and shelf issuance (total up to 200 million shares) at up to a 50% discount to market price. The company urgently needs capital to fund AI expansion, and the existing 63.6 million shares outstanding would be massively diluted—by over 300% if both proposals are fully executed. No financial results or segment performance data are provided, so a balanced assessment of operating health is not possible from this filing alone.

• · Proposal No. 1 (Private Placement) and Proposal No. 2 (Shelf Issuance) each allow up to 100,000,000 shares at up to 50% discount to market closing price.
• · The company explicitly states that the Board has not yet determined final terms and conditions for either offering.
• · Shares will not be sold to officers, directors, or employees.
• · Approval requires a majority of votes cast at the special meeting; broker non-votes and abstentions do not count.
• · Existing shareholders will experience significant dilution if proposals are approved and fully utilized.
• · Concentration of voting power is a risk noted in the filing.
• · No financial performance metrics, revenue, or operating results are disclosed in this filing.
• · Number of shares outstanding does not appear to include any options, warrants, or other derivative securities; beneficial ownership table shows no shares held by named executive officers or directors (all dashes).

09-06-2026

Gossamer Bio is holding a Special Meeting to approve proposals related to an Exchange Offer of its Existing Convertible Notes, which has already resulted in substantial dilution to existing stockholders. The Exchange Offer aims to address $72.0M in debt by issuing new convertible notes and up to 317.6M new shares, leading to existing noteholders owning ~57.5% of outstanding common stock. While the transaction strengthens the balance sheet and eliminates restrictive covenants, it has already caused significant dilution (existing holders' stake reduced to ~42.5% after early settlement) and could further dilute to ~78.7% if all new notes convert.

• · The Exchange Offer is expected to expire on June 16, 2026, with final settlement on June 18, 2026 (the Closing Date).
• · The Proposed Amendments to the Existing Convertible Notes Indenture eliminating substantially all restrictive covenants and certain default provisions became effective upon the Early Settlement Date.
• · The Restated Plan (Proposal No. 2) was approved by the Board on May 15, 2026, effective May 18, 2026, subject to stockholder approval and the Closing Date.
• · As of March 31, 2026, the company had 66,967,972 equity incentive awards outstanding under its plans.
• · Shares available for issuance under the 2019 Incentive Award Plan would increase from 4,619,694 to 81,550,825 on a pro forma basis if Proposal No. 2 is approved.
• · The company's authorized common stock would increase from 700,000,000 to 4,000,000,000 if Proposal No. 3 (Authorized Share Increase) is approved.